1. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Table 1. Characteristics of the bioequivalence crossover randomized controlled trials of healthy subjects included in the meta-analysis

2. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Table 1 (continued). Characteristics of the bioequivalence crossover randomized controlled trials of healthy subjects included in the meta-analysis

3. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Table 2. Characteristics of the parallel-arm randomized controlled trials included in the meta-analysis

4. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Fig. 1. Study selection flow diagram

5. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Fig. 2. Forest plot displaying the pooled weighted ratio of the T/R immunosuppressive drug for the mean Cmax with the corresponding 90% CI. ‘Test' refers to the generic immunosuppressive drug, and ‘reference' to its brand counterpart.

6. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Fig. 3. Forest plot displaying the pooled weighted ratio of the T/R immunosuppressive drug for the mean AUC(0-t), with the corresponding 90% CI. ‘Test' refers to the generic immunosuppressive drug, and ‘reference' to its brand counterpart.

7. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Fig. 4. Forest plot displaying the pooled weighted mean difference of the brand versus generic immunosuppressive drug for the mean Tmax, with the corresponding 95% CI. ‘Test' refers to the generic immunosuppressive drug, and ‘reference' to its brand counterpart.

8. A Systematic Review and Meta-Analysis
Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation:
A Systematic Review and Meta-Analysis
Tsipotis et al. Am J Nephrol 2016;44: (DOI: / )
Fig. 5. Forest plot displaying the pooled weighted mean difference of the brand versus generic immunosuppressive drug for the mean T1/2, with the corresponding 95% CI. ‘Test' refers to the generic immunosuppressive drug, and ‘reference' to its brand counterpart.